The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemi

Trial Profile

The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemi

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2015

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 21 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 27 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top